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Sufficient toxicological data are now available to permit use ofconventional risk assessment techniques
to estimate the hazards associated with human exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-
TCDD). However, many real-world exposures involve complex mixtures ofdibenzodioxins, dibenzofurans,
and related compounds. Historical approaches to risk assessment on such mixtures have ranged from
ignoring all compounds except 2,3,7,8-TCDD itself to assuming that all compounds have potencies equal
to 2,3,7,8-TCDD. An alternative approach which uses existing literature data and analytical results to
calculate the "2,3,7,8-TCDD equivalent" concentration of a mixture in order to "predict" its biological
potency relative to 2,3,7,8-TCDD itself is advanced here. Previously reported in vivo acute and subchronic
studies and some recently obtained analytical chemistry data are integrated here to clarify the utility of
this important approach and to assess the uncertainties associated with its use. This predictive approach,
and various conceptually similar ones, have now found wide applicability to the risk assessment process
associated with exposure to complex mixtures of dioxins, dibenzofurans, and related compounds.
Introduction
Sufficient toxicological data are now available to per-
mit use of conventional risk assessment techniques to
estimate the hazards associated with human exposure
to 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD)
(1). In a few incidents, 2,3,7,8-TCDD has been the only
congener present at toxicologically significant concen-
trations. More commonly, however, real-world expo-
sures involve complex mixtures of compounds with
dioxin-like activity containing up to 75 different chlor-
inated dibenzo-p-dioxin (PCDD), 135 chlorinated diben-
zofuran (PCDF), and 75 chlorinated biphenylene
(PCBE) isomers and congeners. For example, com-
mercial polychlorinated biphenyls (PCBs) (2), emissions
from garbage-burning resource recovery plants (3), and
chemical waste incinerators (4), foodstuffs (5), human
milk (6), and pyrolyzed PCBs or chlorobenzenes (7,8)
all consist of complex mixtures in which 2,3,7,8-TCDD
is a minor component relative to the total PCDD,
PCDF, and PCBE concentration.
Such mixtures present a difficult problem for esti-
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mating human health hazards for at leastthree reasons.
First, analytical chemistry has not yet progressed to
the point that reliable isomer-specific quantitation or
even qualitative identification is possible for the full
range of dioxin-like compounds. For example, the un-
labeled standards needed both for qualitative identifi-
cation and for determination ofresponse factors are not
generally available. In addition, only a very limited set
of 13C- or 37CI-labeled internal standards, which are
necessary to correct for run-to-run variations in recov-
ery, have been prepared. Even modern high resolution
capillary gas chromatographic techniques do not permit
resolution ofall possible congeners. Second, insufficient
toxicological data are available to permit arigorous risk
assessment for most congeners. For example, two-year
carcinogenesis dataare available only for2,3,7,8-TCDD
itself, for 2,7-dichlorodibenzodioxin, and for a mixture
of two 2,3,7,8-substituted hexachlorodibenzodioxins
(hexaCDDs) (9). Single oraldoseguineapig LD50values
have been reported for 16 different dioxins and five
different furans (10). Fewer than 25 of the 75 possible
dioxin and 20 of the 135 possible furan congeners have
been subjected to in vitro determination of biological
activity (10). Finally, there exists a third confounding
factor. The biological potency of the mixture may notEADON ET AL.
simply equal the summation of the activities of the in-
dividual congeners present, if synergistic of antago-
nistic interactions among the mixture's components are
significant.
On February 5, 1981, a fire involving a transformer
containing 60% Aroclor 1254 and 40% tri- and tetra-
chlorobenzenes extensively dispersed a fine oily soot
throughout a 17 story office building in Binghamton,
New York. Chemical analysis demonstrated the pres-
ence of substantial concentrations of PCDDs, PCDFs
and PCBPs in the soot and on various surfaces (11-13).
The necessity of establishing reoccupancy criteria for
the building focused attention on the need to estimate
the biological potency of this complex mixture. Two
conceptually opposed methods can be discerned in pre-
1981 governmental approaches to this problem. The
commonly used early approach (probably encouraged
by lack of analytical chemistry data) was explicitly or
implicitly to ignore all compounds other than 2,3,7,8-
TCDD itself. Alternatively, all compounds detected
were assumed equal in potency to 2,3,7,8-TCDD (14).
Either approach ignores substantial biological evidence
suggesting that the potencies of particular congeners
vary widely, but are, in some cases, negligible when
compared to 2,3,7,8-TCDD. Any realistic attempt to
estimate a mixture's biological potency must therefore
take into account the relative potencies ofits individual
components.
The approach eventually developed to estimate the
hazard associated with exposure to the Binghamton
mixture is a fairly general one. Published short-term
biological data are used to estimate the ratio of the
potency of a particular congener relative to 2,3,7,8-
TCDD. Then, the observed or estimated concentration
of that congener is multiplied by this ratio to estimate
the "2,3,7,8-TCDD equivalent" concentration of that
congener. This 2,3,7,8-TCDD-equivalent concentration
of a particular congener would thus be equated with a
hypothetical concentration of 2,3,7,8-TCDD capable of
producing the same biological effect as the actual con-
centration of that congener. The overall biological po-
tency of the mixture could then be estimated by sum-
ming the TCDD-equivalent concentrations of all
congeners present. Such an approach is only applicable
when the components of the mixture exhibit biological
effects similar to those of2,3,7,8-TCDD.
When first advanced (15), the TCDD-equivalent ap-
proach was novel; more recently, conceptually similar
approaches have been used in assessing other PCB-
related incidents, e.g., the One Market Plaza incident
in San Francisco (16), and in assessing other sources of
environmental exposure, e.g., emissions from resource
recovery plants (17), and these have gained increasing
acceptance as general solutions to the PCDD/PCDF
mixture problem (18). However, it must be emphasized
that the only direct experimental support for this ap-
proach rests on work performed in connection with the
Binghamton incident. Here alone wassufficient contam-
inated material (i.e., "soot") and appropriate laboratory
resources available to allow in vivo comparisons of an
Table 1. Influence of structure and chlorination pattern on
guinea pig oral LD50 (male, Hartley, 200-250 g).
Compound LD50, jg/kg
2,3,7,8-TetraCDD 2.5a
2,3,7,8-TetraCDF 5-1ob
2,3,4,7,8-PentaCDF <boe
1,2,3,7,8-PentaCDD 3.lc
1,2,3,4,7,8-HexaCDD 73c
1,2,3,7,8,9-HexaCDD 60-100C
1,2,3,7,8-HexaCDD 70-100C
2,3,4,6,7,8-HexaCDF 120e
1,2,3,4,6,7,8-HeptaCDD <600c
1,2,4,7,8-PentaCDD 1,125c
2,3,7-TriCDD 29,444c
2,8-DiCDD 730,000c
1,3,6,8-TetraCDD >15,000,000d
aData of Silkworth et al. (19).
bData of Moore et al. (20).
'Data ofMcConnell et al. (21).
dData of Kawamura et al. (22).
eData of McKinney et al. (23).
Ratio
LD,, compound
LD50 2,3,7,8-TCDD
1
2-4
<4
1.2
29
24-40
28-40
48
<240
450
1,200
300,000
600,000
environmental mixture's biological potency relative to
2,3,7,8-TCDD itself, and thus verification ofthe TCDD-
equivalents calculation. The intent of this paper is to
present anintegrated pictureofthe previouslyreported
biological experiments (Table 1) and some recently ob-
tained analytical chemistry data (Table 2) to clarify the
utility of this important approach.
Calculation of TCDD Equivalents
from Chemical Data
Chemical data can be used to estimate the 2,3,7,8-
TCDD equivalent concentration present in a mixture,
provided that the concentrations of the relevant com-
pounds are known and that their biological activities
can be estimated. A biological end point ofspecial con-
cern for these compounds is carcinogenesis (1); unfor-
tunately, only five dibenzodioxins and no dibenzofurans
have been the subject oflifetime animal bioassays (10).
Thus, short-termbioassaydata, which are substantially
more numerous, must be utilized as the basis of the
equivalence calculation. The end point used in the pres-
ent study to estimate relative congener potency is the
single-dose oral LD50 in the guinea pig. This is advan-
tageous, since the LD50ofthemixturein question (soot)
has been experimentally determined (24), thus allowing
direct verification of the calculation. However, since
there is good correlation among various short-term as-
says for these compounds (25-29) any differences be-
tween results from particular short-term assays should
have only minor effects on the calculation (18).
The issue of the relevance of short-term exposure
data tocarcinogenic potency is less clear. However, the
very limited experimental data now available supports
the concept that short- and long-term effects are
roughly proportional. Thus, a mixture of two 2,3,7,8-
substituted hexaCDDs exhibited carcinogenic potency
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Table 2. Concentrations of chlorinated dibenzo-p-dioxins and
dibenzofurans in the Binghamton soot sample used in animal
toxicology experiments.a
Compound Concentration, ppm
Total diCDD 0.5
Total triCDD 0.5
Total tetraCDD 1.5
2,3,7,8-tetraCDD 0.5
Total PeCDD 1.4
1,2,3,7,8-PeCDDb 0.5
Total HxCDD 1.2
1,2,3,4,7,8-HxCDD 0.2
1,2,3,6,7,8-HxCDD 0.2
1,2,3,7,8,9-HxCDD 0.2
Total HpCDD 1.4
1,2,3,4,6,7,8-HpCDD 0.7
Total OCDD 1
Total diCDF 5.9
Total triCDF 27
Total tetraCDF 120
2,3,7,8-tetraCDF 17
Total PeCDF 160
1,2,3,7,8-PeCDF 22
2,3,4,7,8-PeCDF 12
Total HxCDF 64
1,2,3,4,7,8-HxCDF 26
2,3,4,6,7,8-HxCDF 1.2
1,2,3,6,7,8-HxCDF 7.7
1,2,3,7,8,9-HxCDF 1.5
Total HpCDF 26
1,2,3,4,6,7,8-HxCDF 10
Total OCDF 13
aUnless otherwise indicated, concentrations listed are based on a
recent redetermination of the PCDD/PCDF constituents in the soot
using contemporary analytical methodology. This redetermination is
considered more reliable than that previously reported (32), partic-
ularly in view of recent advances in the availability of labeled and
unlabeled standards and chromatography.
bEstimated from data of Silkworth et al. (32).
estimated to be 0.04 times that of 2,3,7,8-TCDD (18);
the ratio of corresponding guinea pig acute oral LD50
values is 0.03. Similarly, in two-year studies of unsub-
stituted dibenzodioxin (30) and 2,7-dichlorodibenzo-
dioxin (31), doses up to 10,000 ppm in the diet elicited
no carcinogenic response in either species. Unchlori-
nated and dichlorinated dibenzodioxins are essentially
inactive relative to 2,3,7,8-TCDD in a battery ofshort-
term bioassays (10).
Table 1 presents the currently available data on
guinea pig acute oral LD50 values for dibenzodioxins
and dibenzofurans. Use ofthis data set to predict the
2,3,7,8-TCDD equivalent concentration in a mixture
(such as the Binghamton soot) is complicated by cer-
tain limitations, particularly the absence of any data
on PCDFs other than 2,3,7,8-TCDF, 2,3,4,7,8-
PeCDF and 2,3,4,6,7,8-HxCDF. The following as-
sumptions will therefore be made about LD50 values
not yet determined.
(1) The ratio ofthe LD50 values ofaparticular PCDF
congenerand2,3,7,8-TCDF willbethe same astheratio
of the LD50 values of the correspondingly substituted
PCDD congener and 2,3,7,8-TCDD. There is no direct
experimental data to support this assumption.
(2) The LD50 values of PCDFs and PCDDs lacking
chlorines at any of the four lateral positions will be
sufficiently high that their influence can be ignored for
most environmentalmixtures. This assumptionis based
on the guinea pig LD50 values of 2,8-diCDD, 2,3,7-
triCDD, and 1,3,6,8-tetraCDD and 1,2,4,7,8-
pentaCDD. All have LD50 values more than 450 times
higher than 2,3,7,8-TCDD itself (Table 1). This simpli-
ficationmaybeinvalid formixtures containingonlyvery
small percentages of 2,3,7,8-substituted isomers.
(3) Introduction of a single additional chlorine sub-
stituent on a 2,3,7,8-substituted congener has essen-
tially no effect on the congener's guinea pig LD50. This
assumption is based on comparison of the LD50 values
of 2,3,7,8-TCDD versus 1,2,3,7,8-pentaCDD, and
2,3,7,8-TCDF versus 2,3,4,7,8-pentaCDF (Table 1).
(4) Introduction of two additional chlorine substi-
tuents on a2,3,7,8-chlorinated congener raises its LD50
by a factor of 30. This assumption is based on compar-
ison ofthe LD50 values of 1,2,3,4,7,8-, 1,2,3,6,7,8-, and
1,2,3,7,8,9-hexaCDD versus 2,3,7,8-TCDD (Table 1).
(5) The LD50 values ofcompounds with more than six
chlorines will be sufficiently high that their influence
can be ignored for most environmental mixtures. This
assumption is based on comparison of the LD50 values
of1,2,3,4,6,7,8-heptaCDD and 2,3,7,8-TCDD (Table 1).
These assumptions require that attention be focussed
only on 2,3,7,8-substituted PCDDs and PCDFs. The
concentration of 2,3,7,8-TCDF in a bulk soot sample
used in the animal toxicology experiments described
later has recently been measured at 17.1 ppm (Table 2);
since the data in Table 1 indicate that the LD50 value
of 2,3,7,8-TCDF is about three times that of 2,3,7,8-
TCDD, this is equivalent in terms of acute toxicity to
a 2,3,7,8-TCDD concentration of about 6 ppm. Based
on assumption (2), other tetraCDFs can be neglected
in this calculation. The two pentaCDF isomers with
2,3,7,8 substitution together total 34 ppm. If, as is re-
quired by assumption (3) and as is consistent with ex-
perimental data for 2,3,4,7,8-pentaCDF, the toxicity of
2,3,7,8-substituted pentaCDFs is considered equal to
that of2,3,7,8-TCDF, this concentration corresponds to
a 2,3,7,8-TCDD equivalent concentration of about 11
Rg/g. The hexaCDFs were measured at 64 ,ug/g. How-
ever, based on assumption (2), only 2,3,7,8-substituted
congeners (1,2,3,4,7,8-, 1,2,3,6,7,8-, and 2,3,4,6,7,8-
hexaCDF) need be considered. Table 1 suggests that
2,3,4,6,7,8-hexaCDF is about 16 times less potent than
2,3,7,8-TCDF itself. Thus, the sum ofobserved 2,3,7,8-
hexaCDF concentrations (36 ,ug/g) corresponds to a
2,3,7,8-TCDD equivalent concentration ofabout 1 ppm
(Table 3). Hepta and octaCDFs have insufficient con-
centrations and biologicalpotencies to contribute tothis
calculation. The concentrations of 2,3,7,8-TCDD and
1,2,3,7,8-PeCDD have each been measured at 0.5 ,ug/
g, corresponding to a "2,3,7,8-TCDD" equivalent con-
centration of 1 ppm. The concentration of hexaCDDs
(1.2 ,ug/g), when adjusted for biological potency by di-
viding by 30, makes a negligible contribution to the
calculation. Similarly, hepta and octaCDDs can be ig-
nored.
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Table 3. Calculation of 2,3,7,8-TCDD equivalents due to various
chlorinated dibenzofurans, dibenzodioxins, and biphenylenes in
Binghamton soot using chemical data.a
A B
Relative activity Relative
compound class activity due 2,3,7,8-TCDD
C vs. to chlorine equivalents,
Concentration dibenzodioxins substitution ppm
2,3,7,8-TCDF/ 1/3 1 6
17.1 ppm
1,2,3,7,8- and 1/3 1 11
2,3,4,7,8-
PeCDF/33.8
ppm
1,2,3,4,7,8-, 1/3 1/16 1
2,3,4,6,7,8-,
1,2,3,6,7,8-,
and 1,2,3,7,8,9-
hexaCDFs/36
ppm
2,3,7,8-TCDD/0.5 1 1 0.5
ppm
1,2,3,7,8-PeCDD/ 1 1 0.5
0.5 ppm
2,3,6,7-TCPB/1.1 1 1 1
ppm
1,2,3,6,7-PeCPB/ 1 1 2
2.3 ppm
a2,3,7,8-TCDD calculated as the productC x A x B.
Together, the dibenzodioxins and dibenzofurans ac-
count for about 19 ,ug/g "2,3,7,8-TCDD equivalents."
Stalling's demonstration (12) that the soot contains a
substantial concentration ofPCBEs complicates the cal-
culation substantially. The only data available relevant
to the biological potency of these derivatives are mea-
surements ofthe cytosolic receptor binding affinity and
the cell keratinization activity of2,3,6,7-tetraCBE (an-
alog of2,3,7,8-TCDD) (33). These results suggest that
2,3,6,7-tetraCBE may have a biological potency similar
to that of its structural analog, 2,3,7,8-TCDD. Unfor-
tunately, nothing is known about the rate ofmetabolic
detoxification ofthese compounds. However, in the ab-
sence of more rigorous data, it will be assumed that
biphenylenes exhibit the same biological potency as the
corresponding dibenzodioxins, and three times the po-
tency of the corresponding dibenzofurans.
Eventoday, quantitative determination ofthe PCBE
concentration in the soot is complicated by the absence
of any reliable labeled or unlabeled biphenylene stan-
dards. As a crude estimate oftheir concentration, Stal-
ling's observation that the PCBEs are present at ap-
proximately 1/15 the concentration of the PCDFs can
be used. This factor, coupled with the foregoing as-
sumption that their biological potency is three times
that ofthe dibenzofurans implies a contribution ofabout
3.4 ppm fromthe biphenylenes. Thus, the best estimate
ofthe overall potency ofthe mixture ofPCDDs, PCDFs
and PCBEs is ca. 22 ppm (Table 3).
Calculation of 2,3,7,8-TCDD
Equivalents from Biological Data
The best test of the various assumptions underlying
the calculation ofTCDD equivalents from chemical data
is to perform an empirical determination of the mix-
ture's biological potency versus 2,3,7,8-TCDD itself.
Since the estimate of biological potency was based on
acute guinea pig oral LD50 data, the most direct point
of comparison requires experimental measurement of
this parameter for the mixture. Female guinea pigs
were administered a single oral dose of a benzene ex-
tract of the soot equivalent to 4, 20, 100, 500, or 1000
mg of soot/kg (24). The soot extract's LD50 was deter-
mined to be 327 mg/kg, based on a 42-day observation
period and calculated by a modification of the method
ofBliss (34). Forpurposes ofcomparison, female guinea
pigs were similarly given single oral doses of 0.1, 0.5,
2.5, 12.5, or 20 p,g/kg 2,3,7,8-TCDD (24). The corre-
sponding calculated LD50 value for 2,3,7,8-TCDD was
19 ,ug/kg in an aqueous vehicle. Thus, by using the re-
lationship (1),
2,3,7,8-TCDD-equivalent concentration (,ug/g)
LD50 for 2,3,7,8-TCDD (Rglg) (1)
LDw for soot (mg/kg)
it can be calculated that the soot has a 2,3,7,8-TCDD
equivalent concentration of (19 Rg/kg)/(327 x 103) ,ug
or 58 ppm.
A more demanding test ofthe TCDD-equivalent con-
cept is to calculate the TCDD equivalent concentration
of the soot based on a variety of exposure end points
induced subehronically. Thus, Binghamton soot was in-
corporated into feed at concentrations of0, 0.2, 1.9, 9.3,
46.3, and 231.5 ppm and fed to guinea pigs for 90 days
(34). In another study, 2,3,7,8-TCDD was incorporated
into feed at concentrations of 0, 2, 10, 76, and 431 ppt
and similarly fed to guinea pigs for purposes of com-
parison (35). End points chosen were those in which
significant, dose-related differences from control values
were observed after subchronic exposure in both stud-
ies. These endpoints included relative (to body) thymus
weights (males), percent ofinitial body weight (males),
triglyceride levels (males) serum ALT levels (females),
and incidence of hepatocellular cytoplasmic inclusion
bodies (females). For the continuous data parameters,
linear regression analysis was performed to obtain the
best straight-line fit for exposure (expressed as ppt
2,3,7,8-TCDD orlogppt2,3,7,8-TCDD in the feed) ver-
sus response using data from the 2, 10, and 76 ppt dose
groups in the present study. Correlation coefficients
were obtained for each line. Response data were nor-
malized by expressing each value as apercentage ofthe
corresponding control value. This was necessary to cor-
rect for small variations between the control values in
each study.
Response data for a particular dose level in the Bing-
hamton soot study were then compared to the standard
curvesgenerated aboveto obtain ahypothetical2,3,7,8-
TCDD concentration inthe feed which would have been
expected to produce the same degree ofresponse. The
"2,3,7,8-TCDD equivalent" concentration of the soot
was then calculated by using Equation (2). The partic-
ulardose levels ofBinghamton sootchosenforthis com-
parison were those in which the degree ofresponse fell
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within the limits of the corresponding standard curve
(1.9 ppm soot level was used).
2,3,7,8-TCDD-equivalent concentration (,ug/g)
hypothetical 2,3,7,8-TCDD concentration in feed (pg/g) (2)
concentration of Binghamton soot in feed (,ug/g)
A different method was employed for analysis ofthe
quantal data obtained forthe incidence ofhepatocellular
cytoplasmic inclusion bodies. Inthis case, use wasmade
of the ED50 (dose level in feed expected to produce a
50% incidence) in order to facilitate comparison of pure
2,3,7,8-TCDD with the Binghamton soot. The ED50 fol-
lowing 90-day exposure to the soot was calculated using
previouslyreportedincidence data(39)by amodification
of the method of Bliss (36). A corresponding ED50 for
subehronic 2,3,7,8-TCDD exposure could not be calcu-
lated from results ofthe present study since a range of
incidences was not obtained. For purposes of compar-
ison, 76 ppt was assumed to be the ED50 dose level for
2,3,7,8-TCDD, since 50% offemale animals at this dose
level exhibited inclusions at a severity grade of + 1 or
greater as previously defined (34,35). The 2,3,7,8-
TCDD equivalent concentration (ppm) of the soot was
then calculated as:
2,3,7,8-TCDD-equivalent concentration (,ug/g)
ED5o for 2,3,7,8-TCDD (ppt)
ED50 for soot (ppm) (3)
Finally, an effective LD50value forprolonged 2,3,7,8-
TCDD exposure was similarly derived by using total
dose versus mortality data from a recovery experiment
in the previous investigation (34). This was compared
with corresponding calculations from the soot study to
yield an equivalent concentration (ppm) by using Equa-
tion 1.
Table 4 summarizes the results of calculations ofthe
2,3,7,8-TCDD equivalent concentration of Binghamton
soot based on dose-response data from previous inves-
tigations (34,35). Excellent dose-response correlations
(r > 0.950) were obtained for the continuous data end-
points (relativethymus weight, % ofinitialbodyweight,
serum triglycerides, and serum ALT) after 2,3,7,8-
TCDD exposure. Log transformation of the 2,3,7,8-
TCDD feed concentrations was required for a good fit
only in the case of serum ALT levels. Calculated
"2,3,7,8-TCDD-equivalent" concentrations for the
Binghamton soot were in good relative agreement for
three of the four end points, with values ranging from
18 to 21 ppm (,ug 2,3,7,8-TCDD/g soot). Calculations
based on serum triglyceride levels resulted in a some-
what lower value of 5 ppm.
Data on the incidence of hepatocellular cytoplasmic
inclusion bodies in female guinea pigs fed Binghamton
soot were employed to determine a value of 7.6 ppm
(2.7 to 21.6 ppm, 95% confidence range) as the ED50
dose level ofsoot for this lesion. Using a value of76 ppt
for the ED50 dose level following exposure to pure
2,3,7,8-TCDD, the "2,3,7,8-TCDD-equivalent" concen-
tration of the soot was determined to be 10 ppm (4 to
Table 4. Calculated 2,3,7,8-TCDD-equivalent concentrations of
the Binghamton soot for various dose-related endpoints
following subchronic exposure.'
2,3,7,8-TCDD
equivalent concen-
End point Sex Methodb rc tration in soot, ppm
Relative thymus M Linear 0.951 19d
weight (decrease)
% ofinitial body M Linear 0.994 21d
weight (decrease)
Serum triglycerides M Linear 0.998 5d
(increase)
Serum ALT F Log 0.960 18e
(decrease)
Hepatocellular F EDro 10 (4-28)f
cytoplasmic
inclusion bodies
Mortality M LD5 - 2 (1-3)f
aResponsedatafromthepreviouslyreportedBinghamtonsoot(34),
and 2,3,7,8-TCDD (35) subehronic studies 2,3,7,8-TCDD-equivalent
concentrations for the soot.
bMethodbywhich2,3,7,8-TCDD dose-response standardcurvewas
constructed: Linear = linear regression analysis of dose level (ppt)
vs. response; LOG = linear regression analysis oflogdose level (ppt)
vs. response; ED50 = calculation of ED50 dose level by method of
Carmines et al. (36); LD,0 = calculation of LD,0 for subchronic ex-
posure by method of Carmines et al. (36).
cCorrelation coefficient from linear regression analysis.
dCalculated using response data from 1.9 ppm Binghamton soot
dose level.
eCalculated using response data from 3.9 ppm Binghamton soot
dose level.
f95% confidence limits.
28 ppm, 95% confidence limits). A similar approach was
employed for calculation of an effective LD50 for soot
exposure, except that total soot consumption was used
instead ofsootconcentrationinthe feed. This LD50dose
was determined to be 383 mg soot/kg (186 to 790 mg/
kg, 95% confidence range). Comparison with the effec-
tive LD50 of0.8 pug 2,3,7,8-TCDD/kg (0.6 to 1.1 ,ug/kg,
95% confidence limits) yielded a value of 2 ppm (1 to 3
ppm, 95% confidence limits) for the 2,3,7,8-TCDD-
equivalent concentration of the Binghamton soot.
Comparison of Chemical and
Biological Calculations
The most direct test of the assumptions underlying
the calculation of2,3,7,8-TCDD equivalents from chem-
ical data and published acute oral LD50 values is com-
parisonwiththebiologicalcalculationbasedonthe acute
oral LD50 of the mixture and of 2,3,7,8-TCDD itself.
The chemical data-based 2,3,7,8-TCDD equivalents es-
timate of 22 ppm is in reasonable agreement with the
experimentally determined value of 58 ppm.
From a practical perspective, however, the predic-
tions ofmagnitude ofacute toxicity expressedby a mix-
ture is of less interest than prediction of the mixture's
subehronic and chronictoxicity. The sixsubehronicend-
points listed in Table 4, although not necessarily rep-
resenting adverse effects of great clinical importance,
nevertheless serve as sensitive indicators of exposure.
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The calculated equivalent concentration values varied
over an approximately tenfold range (2 to 21 ppm), de-
pending upon the end point chosen. Such a range is not
unexpected, since various soot components might be
more or less effective than 2,3,7,8-TCDD in producing
a specific end point. While the soot appeared to be very
effective in causing alterations in thymus weight, body
weight, and serum triglyceride levels, it was less ef-
fective at causing death. Taken together, these findings
suggest that biologically based calculations of 2,3,7,8-
TCDD equivalent concentrations are best based on a
range ofbiological end points.
It is notable that for the Binghamton soot, use ofthe
acute oral LD50 as the end point resulted in higher ap-
parent toxicity (i.e., the highest 2,3,7,8-TCDD equiv-
alent concentration) than the various subchronic end-
points. Thus, use of the acute LD50 or use of the
chemical data to perform a calculation may provide a
conservative estimateoftheacuteorsubchronicactivity
of the mixture. However, the observation that the
2,3,7,8-TCDD equivalent concentration varied byabout
an order ofmagnitude when calculated byusing various
subchronically induced end points is an indication ofthe
uncertainty associated with the use of any single bio-
logical end point or of chemical analysis data alone to
estimate a mixture's potency.
Conclusions
The acute oral LD50 of a soot sample containing a
complex mixture of PCDDs, PCDFs, and PCBEs has
been shown to correspond to that ofa hypothetical ma-
terial containing only2,3,7,8-TCDD at 58ppm. The cor-
responding 2,3,7,8-TCDD equivalent concentration cal-
culated by using various dose-related subchronic end
points ranged from 2 to 19 ppm. Conversely, using ex-
isting literature data to estimate the potency of indi-
vidual congeners and the results of chemical analyses
on the soot, it can be "predicted" that the soot contains
ca. 22 ppm 2,3,7,8-TCDD equivalents. In light of un-
certainties in the chemical analyses and toxicological
determinations, as well as uncertainties in the sample
congener toxicity data upon which this calculation re-
lies, the agreement between observed and predicted
concentrations is good. However, the substantial vari-
ation in the results ofthe "equivalents" calculation de-
pending on endpoint chosen clearly shows that any de-
termination based on a single end point or any
calculation based on chemical concentrations has a sub-
stantial uncertainty associated with it. Nevertheless,
these uncertainties will often be small in comparison to
the many uncertainties and approximations inherent in
ariskassessment forasinglecompound, suchas2,3,7,8-
TCDD. It appears likely that this approach, or a con-
ceptually similar one, will find increasing use in the
evaluation of the hazard posed by complex mixtures.
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